Most international manufacturers approach Brazil with the same initial assumption.
“This is going to be complicated.”
And to be fair, there are reasons for that perception.
ANVISA has a rigorous regulatory framework. Documentation requires precision. Timelines need to be managed carefully.
So naturally, the focus goes there first.
How do we get approval?
How long will it take?
What do we need to prepare?
All valid questions.
But after working with manufacturers entering Brazil for many years, we’ve seen something that tends to surprise companies.
Getting into Brazil isn’t usually the hardest part.
Getting the structure wrong at the beginning is.
The Part That Doesn’t Show Up in the Checklist
Most market entry plans follow fairly standard logic.
Regulatory approval → local partner → distribution → sales.
On paper, it looks straightforward.
But what often doesn’t get enough attention is how these pieces are connected—and how early decisions shape everything that comes after.
Because in Brazil, structure isn’t just operational.
It’s strategic.
And once it’s in place, changing it can be far more difficult than expected.
Where Complexity Actually Lives
The complexity of Brazil’s not just regulatory.
It sits in the intersection of multiple layers:
Regulation. Taxation. Importation. Distribution. Hospital access.
Individually, each one’s manageable.
But when they’re not aligned, friction starts to appear.
We’ve seen companies receive regulatory approval without a clear import structure—leading to delays at customs.
Others had distribution agreements in place, but no alignment with hospital procurement dynamics—resulting in slow adoption.
In many cases, the issue wasn’t execution.
It was how the structure had been designed from the beginning.
Small Decisions, Long-Term Consequences
Some of the most impactful decisions are made very early—and often treated as simple operational choices.
For example:
Assigning the product registration to a distributor because it seems efficient.
Choosing a single partner to handle regulatory, importation, and sales without evaluating long-term flexibility.
Building a national distribution model before understanding how different regions behave.
Individually, these decisions make sense.
Collectively, they can create a structure that’s difficult to adjust later.
We’ve seen companies that needed to change distributors but couldn’t do so without affecting their regulatory position.
Others had pricing challenges because the initial tax structure wasn’t optimized.
Not because the strategy was wrong.
But because the structure didn’t allow it to evolve.
Brazil Requires Flexibility from the Start
One of the defining characteristics of the Brazilian healthcare market’s that it evolves.
Commercial strategies change.
Distribution needs to be expanded.
New opportunities appear in different regions or specialties.
Manufacturers who succeed here usually build their entry model with that in mind.
They don’t try to “lock everything in” from day one.
Instead, they create a structure that allows them to adapt over time.
That often means:
Separating regulatory control from commercial relationships. Working with partners who allow flexibility. Thinking beyond initial entry and planning for growth.
It’s less about having the perfect model on day one.
And more about having a model that can evolve.
The Difference Between Entering and Establishing
There’s a subtle but important distinction in Brazil.
Some companies enter the market.
Others establish a presence.
The difference usually comes down to structure.
Entering can be relatively fast.
But building a sustainable position—one that allows growth, adjustments, and expansion—depends on how well the foundation was set.
We’ve seen both scenarios.
Companies that moved quickly but later had to restructure key elements of their operation.
And companies that took a more deliberate approach early on—and moved with much more confidence afterward.
A Different Way to Think About Market Entry
Instead of asking:
“How do we enter Brazil?”
A more useful question might be:
“How do we structure our presence in Brazil so it works not just now, but later?”
That shift in perspective changes the conversation.
It brings attention to decisions that don’t always seem urgent but end up being critical.
And it helps avoid situations where growth’s limited not by the market, but by the initial setup.
Brazil’s Complex. But It’s Not Unpredictable.
There’s a tendency to see Brazil as a difficult market.
And yes, it requires attention.
But in many cases, what creates difficulty isn’t the market itself—it’s the misalignment between structure and strategy.
When those two are aligned, things tend to move more smoothly.
Regulatory processes become predictable.
Operations become manageable.
Market access becomes clearer.
It’s a Conversation Worth Having Early
Most of the challenges companies face in Brazil don’t come from major mistakes.
They come from small decisions made without full visibility.
And they’re often avoidable.
If Brazil’s part of your international roadmap, taking the time to think through the structure early can make a significant difference later.
Because in this market, success isn’t defined by how fast you enter.
But how well you build what comes next.
Thinking About Brazil Mark
Find out more about BPO in RA! 
*Budget for registration ownership transfer, Market Access Strategy, and BPO in RA services for your company: www.brisa.com.br 
